ES2135581T3 - Gen de la enfermedad de von hippel-lindau (vhl) y cdna correspondiente y metodos para detectar portadores del gen de la enfermedad de vhl. - Google Patents

Gen de la enfermedad de von hippel-lindau (vhl) y cdna correspondiente y metodos para detectar portadores del gen de la enfermedad de vhl.

Info

Publication number
ES2135581T3
ES2135581T3 ES94916774T ES94916774T ES2135581T3 ES 2135581 T3 ES2135581 T3 ES 2135581T3 ES 94916774 T ES94916774 T ES 94916774T ES 94916774 T ES94916774 T ES 94916774T ES 2135581 T3 ES2135581 T3 ES 2135581T3
Authority
ES
Spain
Prior art keywords
vhl
gene
disease
methods
lindau
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94916774T
Other languages
English (en)
Inventor
Michael I Lerman
Farida Latif
Berton Zbar
Marston Linehan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of ES2135581T3 publication Critical patent/ES2135581T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57575—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA INVENCION SE REFIERE AL GEN DE LA ENFERMEDAD DE VON HIPPELLINDAU (VHL) Y A SU CORRESPONDIENTE CADN. SE DESCRIBEN METODOS PARA LA DETECCION LOS PORTADORES DEL GEN DE LA ENFERMEDAD UTILIZANDO SONDAS DERIVADAS DEL CDNA.
ES94916774T 1993-05-14 1994-05-12 Gen de la enfermedad de von hippel-lindau (vhl) y cdna correspondiente y metodos para detectar portadores del gen de la enfermedad de vhl. Expired - Lifetime ES2135581T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/061,889 US5654138A (en) 1993-05-14 1993-05-14 Von hippel-lindau (VHL) disease gene and corresponding cDNA and methods for detecting carriers of the VHL disease gene

Publications (1)

Publication Number Publication Date
ES2135581T3 true ES2135581T3 (es) 1999-11-01

Family

ID=22038796

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94916774T Expired - Lifetime ES2135581T3 (es) 1993-05-14 1994-05-12 Gen de la enfermedad de von hippel-lindau (vhl) y cdna correspondiente y metodos para detectar portadores del gen de la enfermedad de vhl.

Country Status (11)

Country Link
US (2) US5654138A (es)
EP (1) EP0698093B1 (es)
JP (1) JP3650397B2 (es)
AT (1) ATE182622T1 (es)
AU (1) AU696234B2 (es)
CA (1) CA2162928A1 (es)
DE (1) DE69419748T2 (es)
DK (1) DK0698093T3 (es)
ES (1) ES2135581T3 (es)
GR (1) GR3030876T3 (es)
WO (1) WO1994026894A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6312890B1 (en) * 1993-05-14 2001-11-06 The United States Of America As Represented By The Department Of Health And Human Services Partial intron sequence of von hippel-lindau (VHL) disease gene and its use in diagnosis of disease
US6013436A (en) * 1994-07-08 2000-01-11 Visible Genetics, Inc. Compositions and methods for diagnosis of mutation in the von Hippel-Lindau tumor suppressor gene
AU7142796A (en) * 1995-10-02 1997-04-28 Erasmus University Rotterdam Diagnosis method and reagents
US5888736A (en) * 1995-12-22 1999-03-30 Visible Genetics, Inc. Method, compositions and kit for detection and identification of microorganisms
US5789168A (en) * 1996-05-01 1998-08-04 Visible Genetics Inc. Method for amplification and sequencing of nucleic acid polymers
US5830657A (en) * 1996-05-01 1998-11-03 Visible Genetics Inc. Method for single-tube sequencing of nucleic acid polymers
US6083699A (en) * 1996-05-01 2000-07-04 Visible Genetics Inc. Method for bi-directional sequencing of nucleic acid polymers
US6413718B1 (en) 1996-05-01 2002-07-02 Visible Genetics Inc. Method for sequencing of nucleic acid polymers
US6214555B1 (en) 1996-05-01 2001-04-10 Visible Genetics Inc. Method compositions and kit for detection
DE69709087T2 (de) * 1996-05-01 2002-04-25 Visible Genetics, Inc. Verfahren zum nachweis und zur identifizierung von mikroorganismen
ATE497018T1 (de) * 2000-05-19 2011-02-15 Eragen Biosciences Inc Materialien und methoden zum nachweis von nukleinsäuren
US6977161B2 (en) 2000-10-14 2005-12-20 Eragen Biosciences, Inc. Solid support assay systems and methods utilizing non-standard bases
US7222059B2 (en) 2001-11-15 2007-05-22 Siemens Medical Solutions Diagnostics Electrophoretic trace simulator
US20050208023A1 (en) * 2002-07-19 2005-09-22 Krissansen Geoffrey W Tumor treating composition and methods
NZ520322A (en) * 2002-07-19 2005-04-29 Auckland Uniservices Ltd Tumor treating composition and methods
AU2003296438A1 (en) * 2002-12-24 2004-07-29 North Carolina State University Increasing gamete production with a gene switch
US7494467B2 (en) * 2004-04-16 2009-02-24 Ethicon Endo-Surgery, Inc. Medical system having multiple ultrasound transducers or an ultrasound transducer and an RF electrode
US9261498B2 (en) * 2005-03-17 2016-02-16 The Regents Of The University Of California Biomarker for sensitivity to mTOR inhibitor therapy in kidney cancer
WO2012166824A2 (en) * 2011-05-31 2012-12-06 Oregon Health And Science University Methods and kits that identify tumors responsive to src inhibitors
EP2747552A1 (en) * 2011-08-23 2014-07-02 University of South Florida Inducible mouse models of lung injury and lung diseases
CN110066874A (zh) * 2019-04-26 2019-07-30 复旦大学附属华山医院 血管母细胞瘤分型诊断试剂盒

Also Published As

Publication number Publication date
US5654138A (en) 1997-08-05
JPH08511158A (ja) 1996-11-26
GR3030876T3 (en) 1999-11-30
ATE182622T1 (de) 1999-08-15
WO1994026894A1 (en) 1994-11-24
EP0698093A1 (en) 1996-02-28
AU6833794A (en) 1994-12-12
CA2162928A1 (en) 1994-11-24
US5759790A (en) 1998-06-02
DE69419748D1 (de) 1999-09-02
JP3650397B2 (ja) 2005-05-18
DK0698093T3 (da) 1999-11-29
EP0698093B1 (en) 1999-07-28
AU696234B2 (en) 1998-09-03
DE69419748T2 (de) 1999-12-09

Similar Documents

Publication Publication Date Title
ES2135581T3 (es) Gen de la enfermedad de von hippel-lindau (vhl) y cdna correspondiente y metodos para detectar portadores del gen de la enfermedad de vhl.
DE69433180D1 (de) Felder von nukleinsaeuresonden auf biologischen chips
DE69033850D1 (de) Nukleinsäuresonden zum Nachweis von HPV-Transkripts
DE68923035D1 (de) Nachweis von Lanthanid-markierte Nukleotide mittels zeitgelöster Fluorometrie.
NO905460D0 (no) Broennsonde.
ID19528A (id) Konfigurasi elektreoda untuk pengamatan matrik alat pendeteksi molekul
ES2001056A6 (es) Un procedimiento para la preparacion de polipeptidos y sus derivados que contienen oxa- y azahomocicloestatina.
DK1032705T3 (da) Probearrays og fremgangsmåder til at benytte probearrays til at skelne mellem DNA
DE69032143D1 (de) Zerstörungsfreie Prüfung von Strukturelementen
DE69132905D1 (de) Detektion von Nukleinsäuresequenzen
PT641343E (pt) Derivados de 4-mercaptoacetilamino-¬2|benzazapinona (3) e a sua utilizacao como inibidores de encefalinase
NO864273D0 (no) Fremgangsmaate for deteksjon og skjuling av feil ved benyttelse av forutsagte signalverdier.
DK531887A (da) Mutagenese- og screeningsfremgangsmaade samt produkt
NO895295L (no) Hurtigtesting av gjenstander.
NO962188L (no) Nye apoptose-modulerende proteiner, DNA som koder for proteinene og fremgangsmåter for anvendelse derav
KR900021177U (ko) Tab번인 시험용 소켓
IT7869517A0 (it) Reattivo per la rivelazione e per la determinazione di enzimi
DE3673928D1 (de) Nachweis von retikulocyten.
ITRM910286A1 (it) Procedimento per rivelare sequenze di acidi nucleici e kit per la sua utilizzazione.
DE69638341D1 (de) Anzeigeprozessorsystem für eine punktorganisierte Anzeige von Wellenformdaten
DE69008178D1 (de) Analyse von vitamin b12.
NO901614D0 (no) Luminescens-undersoekelse av enzymer.
DE69008217D1 (de) System zum Prüfen von Kabelstücken.
ES2023151B3 (es) Derivados de p-hidroxicinamamida e inhibidor de melanina que los contiene.
ES2154648T3 (es) Deteccion y amplificacion de acidos nucleicos blanco con actividad exonucleolitica.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 698093

Country of ref document: ES